Found: 26
Select item for more details and to access through your institution.
Causes and Clinical Presentation of Drug-Induced Dermatomyositis: A Systematic Review.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 210, doi. 10.1001/jamadermatol.2023.5418
- By:
- Publication type:
- Article
The Problematic Legacy of Skin-Thickness Measurement in Race-Based Dermatology Research.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
Development and Validation of a Patient-Reported Outcome Measure to Assess Disease Control in Chronic Prurigo.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 187, doi. 10.1001/jamadermatol.2023.5519
- By:
- Publication type:
- Article
Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 179, doi. 10.1001/jamadermatol.2023.5425
- By:
- Publication type:
- Article
Amending the Pain Scale Used for Postoperative Pain Studies—Reply.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 239, doi. 10.1001/jamadermatol.2023.5252
- By:
- Publication type:
- Article
Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab Treatment.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 237, doi. 10.1001/jamadermatol.2023.4744
- By:
- Publication type:
- Article
Clinical Characteristics of Erythema Nodosum and Associations With Chronicity and Recurrence.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 229, doi. 10.1001/jamadermatol.2023.5306
- By:
- Publication type:
- Article
Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 172, doi. 10.1001/jamadermatol.2023.5362
- By:
- Publication type:
- Article
Lived Experience of Acne and Acne Treatment in Transgender Patients.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 164, doi. 10.1001/jamadermatol.2023.5355
- By:
- Publication type:
- Article
Innovation in Development of Dermatologic Drugs Approved by the US Food and Drug Administration Between 2012 and 2022.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 226, doi. 10.1001/jamadermatol.2023.5036
- By:
- Publication type:
- Article
Adenopathy and an Extensive Skin Patch Overlying a Plasmacytoma Syndrome.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 220, doi. 10.1001/jamadermatol.2023.4157
- By:
- Publication type:
- Article
Melanoma Incidence Rates Among Non-Hispanic American Indian/Alaska Native Individuals, 1999-2019.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 148, doi. 10.1001/jamadermatol.2023.5226
- By:
- Publication type:
- Article
Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis: A Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 156, doi. 10.1001/jamadermatol.2023.4990
- By:
- Publication type:
- Article
Potential Role of Tranexamic Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation—Reply.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 240, doi. 10.1001/jamadermatol.2023.5463
- By:
- Publication type:
- Article
Amending the Pain Scale Used for Postoperative Pain Studies.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Successful Treatment of Recalcitrant Mpox Lesions With Intralesional Cidofovir in a Patient With HIV/AIDS.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 235, doi. 10.1001/jamadermatol.2023.4727
- By:
- Publication type:
- Article
Potential Role of Tranexamic Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Risk of Alopecia Areata After COVID-19.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 232, doi. 10.1001/jamadermatol.2023.5559
- By:
- Publication type:
- Article
Olmsted Syndrome.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 218, doi. 10.1001/jamadermatol.2023.4152
- By:
- Publication type:
- Article
High Melanoma Rates in the American Indian and Alaska Native Population—A Unique Challenge.
- Published in:
- 2024
- By:
- Publication type:
- Opinion
Erythroderma in a Patient With Thymoma-Associated Myasthenia Gravis.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 224, doi. 10.1001/jamadermatol.2023.4228
- By:
- Publication type:
- Article
Error in Figure 2.
- Published in:
- 2024
- Publication type:
- Correction Notice
Newborn Girl Presenting With Erythema and Blisters.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 222, doi. 10.1001/jamadermatol.2023.4221
- By:
- Publication type:
- Article
Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 204, doi. 10.1001/jamadermatol.2023.5058
- By:
- Publication type:
- Article
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 199, doi. 10.1001/jamadermatol.2023.5051
- By:
- Publication type:
- Article
Risk of Subsequent Vitiligo in Transplant Recipients With Comorbid Graft-vs-Host Disease.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 2, p. 194, doi. 10.1001/jamadermatol.2023.4933
- By:
- Publication type:
- Article